KRAS and pancreatic neoplasm: Non-transformed human pancreatic nestin expressing (HPNE) and mutant KRAS G12D-transformed HPNE (HPNE-KRAS) cells were used in this study to evaluate the impact of alcohol in a defined cellular and genetic context relevant to the most common early mutation event in pancreatic cancer [20].